Licensing is one of the safest, most effective ways to commercialize your MedTech IP — without building a company from scratch.
Sign up for immediate access to the replay — free for MedTech innovators, inventors, and IP owners.
No spam. No commitment. Unsubscribe anytime.
Instead of facing the immense challenge of building a company from the ground up, discover how to partner with established healthcare businesses that have the funding, expertise, and distribution to commercialize your medical technology — and pay you royalties to do it.
Building a medical technology company is extraordinarily capital-intensive, regulatory-heavy, and time-consuming. Most innovators underestimate what it takes — and run out of runway before reaching market.
Licensing offers a fundamentally different path. Partner with companies that already have FDA clearances, clinical relationships, sales infrastructure, and distribution — and let them pay you to bring your innovation to patients.
Licensing lets you monetize your MedTech IP without raising capital, hiring a team, or navigating the full regulatory pathway on your own.
The right licensee already has the clinical relationships, reimbursement codes, and sales force your innovation needs to reach market.
Structured licensing deals create ongoing royalty income that compounds as your partner scales — far more valuable than a flat IP sale.
Properly structured agreements ensure you retain control of your IP while maximizing its commercial reach and royalty potential.
Medical technology has unique commercialization dynamics that make licensing not just viable — but often the optimal strategy for IP owners at every stage.
Large MedTech companies have hospital relationships, GPO contracts, and sales infrastructure that would take years and millions to replicate independently.
FDA clearance is expensive and complex. The right licensing partner may already have pathways your innovation can fit into — dramatically reducing time to market.
Development stage, clinical evidence, and patent strength all affect your royalty rate. This workshop shows you how to position your IP to command the highest value.
Unlike selling your IP outright, a licensing deal generates ongoing royalties — potentially for decades — tied to every unit sold or procedure performed.
Partnering with a company that already has clearances, manufacturing, and sales channels can compress your time-to-market from years to months.
Licensing shifts the commercialization burden — and capital risk — to your partner. You focus on innovation; they focus on market execution.
Six focused sessions covering everything from MedTech IP fundamentals to running a successful licensing campaign and negotiating royalty rates.
A clear overview of patents, trademarks, trade secrets, know-how, and regulatory IP — what each is, how to protect it, and how each performs differently in licensing.
How to create, organize, and manage a MedTech licensing campaign — from identifying target licensees to structuring outreach and managing the process through close.
A step-by-step walkthrough of how a MedTech licensing deal moves from initial contact to signed agreement — including the stages most innovators never see coming.
What to look for in a MedTech licensing partner — strategic fit, market position, clinical capability, and financial strength — and how to qualify them before negotiating.
How royalty rates are set in MedTech, what drives value in a licensing negotiation, and proven strategies for maximizing the total economic return on your IP.
A focused discussion with Rand Brenner about your specific IP and licensing situation — real answers to real questions from MedTech innovators and IP owners.
If you've developed medical technology and are evaluating how to commercialize it — without building an entire company — this workshop is directly relevant.
Independent inventors with patented or patent-pending medical device innovations looking for the fastest path to commercialization.
Early-stage companies with validated technology that want to scale through licensing partnerships rather than — or alongside — building a direct commercial operation.
Technology transfer offices and research teams with medical innovations looking for structured commercialization through industry licensing partners.
Innovators in diagnostics, telehealth, clinical decision support, and healthcare software exploring licensing as a go-to-market strategy.
Clinicians, surgeons, and healthcare practitioners who have developed patentable solutions to clinical problems and want to license them to device companies.
Professionals advising medical technology companies on commercialization strategy who want to add IP licensing to their toolkit.

Rand Brenner is President and CEO of Licensing Consulting Group, an IP consultancy specializing in strategic consulting, licensing management, and IP due diligence across medical technology, consumer products, entertainment, and regulated industries. He has an extensive career as both licensee and licensor, with a track record spanning multiple industries and major brand properties.
Rand is a professional speaker on licensing and has presented at business events, conferences, and trade shows worldwide. His book Hidden Wealth: The Money Making Power of Licensing was published in 2019. His work has been featured in the Licensing Journal and Intellectual Property Magazine.
Schedule a private 15-minute strategy session with Rand Brenner to evaluate your medical technology IP and identify your best licensing pathway to market.
15 minutes · Free · No obligation · Via video call